Up Next
Back to Show
PBS News Hour
FDA criticized for Alzheimer's drug approval process
New findings from a congressional investigation into the Food and Drug Administration and the biotech company Biogen find the FDA broke its own protocols to approve a new Alzheimer’s drug last year. The report said the FDA worked too closely with Biogen despite significant concerns over the limited benefits and side effects of the new drug, Aduhelm. Geoff Bennett reports.
Support Provided By
26:45
With monkeypox cases on the rise, concerns grow over disparities in access to vaccines, testing and treatment.
56:41
President Biden asks Congress to suspend the federal gas tax temporarily as rising prices pinch Americans nationwide.
26:38
Ukrainian officials say they've won the battle for Kyiv as Russia repositions its forces and begins a new offensive in the east.
26:39
Ukraine's President Zelenskyy says Russia engaged in genocide following shocking images of civilians killed outside Kyiv.
26:35
Joe Biden speaks out against the war while in Poland today as Russian airstrikes of Ukrainian cities continue.
26:35
The Russian invasion in Ukraine enters its fourth week as President Zelensky calls for peace talks and accuses Russia of war crimes in Mariupol.
26:35
Ukraine's president calls for more peace talks as the humanitarian toll from the Russian invasion grows, Alabama's Senate passes important changes to its constitution, and more.
23:59
The Russian invasion of Ukraine continues as a second attempt at a ceasefire fails and refugee numbers grow — a look at the situation on the ground and how the war is playing out globally.
56:45
Friday on the NewsHour, as Russian forces close in on Kyiv and Ukrainians struggle to repel the invasion, "PBS NewsHour" talks to the head of NATO about the West's response.
56:42
Russian airstrikes bombard Ukraine as ground forces advance on the nation's capital, and elsewhere, forcing civilians to flee for their safety.